This information is only accessible for healthcare professionals seeking more information on Reagila®(cariprazine) for the treatment of schizophrenia in adult patients. Please register here for further clinical and practical information.
- Home
 - 
                                Over Reagila
- 
                                                Werkingsmechanisme
Werkingsmechanisme
 - 
                                                Klinische data
Klinische data
- REAGILA in Patients with Acute Exacerbation of Schizophrenia
 - REAGILA in The Long-Term Treatment of Schizophrenia
 - REAGILA Controls Negative Symptoms in Schizophrenia
 - Controlling Everyday Functioning with REAGILA®
 - REAGILA’s Effects on Primary and Secondary Negative Symptoms: Pseudospecificity
 - The Safety and Tolerability Profile of REAGILA
 - The Management of Akathisia
 - Cariprazine and Weight Gain
 
 
 - 
                                                
 - 
                                Reagila Voorschrijven
 - 
                                Educatie & events
 - 
                                Aan te vragen